SCHEMBL7386474

SCHEMBL7386474

O=CN(O)C[C@H](Cc1ccccc1)C(=O)NCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MME P08473 6/20 0.62
ACE P12821 4/20 0.62
ALDH1A1 P00352 2/20 0.62
HPGD P15428 1/20 0.62
MAPK1 P28482 1/20 0.62
HSD17B10 Q99714 1/20 0.62
MEN1 O00255 1/20 0.62
MAPT P10636 1/20 0.62
ECE1 P42892 1/20 0.62
BLM P54132 1/20 0.62
NPEPPS P55786 1/20 0.62
KMT2A Q03164 1/20 0.62
BMP1 P13497 1/20 0.52
MMP12 P39900 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386469 1.00 MME (0.62) MMEACEALDH1A1HPGDMAPK1
SCHEMBL7386471 1.00 MME (0.62) MMEACEALDH1A1HPGDMAPK1
SCHEMBL29811102 0.85 BMP1 (0.51) MMEACEBMP1MMP12
SCHEMBL10447979 0.82 MME (0.81) MMEACEALDH1A1HPGDMAPK1
SCHEMBL4956230 0.81 BMP1 (0.44) MMEACEALDH1A1HPGDMAPK1
SCHEMBL5091426 0.81 LTA4H (0.49) MMEBMP1MMP12
SCHEMBL29630188 0.81 LTA4H (0.49) MMEBMP1MMP12
SCHEMBL5091424 0.80 MME (0.56) MMEACE
SCHEMBL29811101 0.80 MME (0.56) MMEACE
SCHEMBL29811098 0.80 MME (0.56) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0566157-A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1993-10-20 EP disclosed
US-4749688-A Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-06-07 US disclosed
EP-0254032-A2 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-01-27 EP disclosed